Multidisciplinary management of SCC and BCC 1

Squamous cell carcinoma (SCC) and basal cell carcinoma (BCC) are the most common forms of non-melanoma skin cancers. They have a wide clinical and pathological presentation, and early detection and treatment is vital to reduce the morbidity and mortality associated with these diseases.

In this podcast, our multidisciplinary panel discuss:
• the pathology and aetiology of SCCs and BCCs
• when a GP should refer their patient
• the role of surgery
• when radiotherapy is indicated in the definitive and adjuvant setting
• how systemic therapy can play a role in advanced disease.

In addition, the panel review two cases to solidify the learnings.

This podcast is suitable for Medical Oncologists, Surgeons, Dermatologists, GPs, Nurses and other healthcare professionals.

Subscribe to our new Melanoma Insights for Professionals podcasts via iTunes or Spotify or for Android devices, click here or search for 'Melanoma Insights for Professionals' your favourite podcast app.

Please note that this podcast was accurate at the time of recording (March 2021) but may not reflect the rapidly evolving treatment landscape and approvals in Australia.

SPEAKERS

Dr Robert Rawson Pathologist, Melanoma Institute Australia and Royal Prince Alfred Hospital Declaration of Interest

Dr Kerwin Shannon Surgical Oncologist and Head and Neck Surgeon, Melanoma Institute Australia and Chris O’Brien Lifehouse Declaration of Interest

Prof Angela Hong Radiation Oncologist, Melanoma Institute Australia |Clinical Professor, The University of Sydney Declaration of Interest

Dr Ines Silva Medical Oncologist and Researcher, Melanoma Institute Australia | Fellow, Westmead Hospital Declaration of Interest

This learning module was proudly supported through unrestricted educational grants from:    

• Module1.1
  Multidisciplinary management of SCC and BCC | 46 min
  33 min